These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32273709)

  • 21. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan.
    Hsieh CJ; Chang CC; Lin CC
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.
    Karttunen K; Karppi P; Hiltunen A; Vanhanen M; Välimäki T; Martikainen J; Valtonen H; Sivenius J; Soininen H; Hartikainen S; Suhonen J; Pirttilä T;
    Int J Geriatr Psychiatry; 2011 May; 26(5):473-82. PubMed ID: 21445998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    Rosenberg PB; Lanctôt KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R
    J Alzheimers Dis; 2016 Aug; 54(1):373-81. PubMed ID: 27567808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
    Treiber KA; Lyketsos CG; Corcoran C; Steinberg M; Norton M; Green RC; Rabins P; Stein DM; Welsh-Bohmer KA; Breitner JC; Tschanz JT
    Int Psychogeriatr; 2008 Jun; 20(3):538-53. PubMed ID: 18289451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of neuropsychiatric symptoms in Alzheimer's disease and vascular dementia.
    Fernández-Martínez M; Castro J; Molano A; Zarranz JJ; Rodrigo RM; Ortega R
    Curr Alzheimer Res; 2008 Feb; 5(1):61-9. PubMed ID: 18288933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease].
    Abizanda P; López-Jiménez E; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; Paterna G; Martínez-Sánchez E
    Rev Esp Geriatr Gerontol; 2009; 44(5):238-43. PubMed ID: 19660838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    Zhou Y; Wang Y; Quan M; Zhao H; Jia J
    J Alzheimers Dis; 2021; 81(2):583-595. PubMed ID: 33814442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
    Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
    Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of Neuropsychiatric Symptoms with Falls in Alzheimer's Disease - Does Exercise Modify the Risk?
    Roitto HM; Kautiainen H; Öhman H; Savikko N; Strandberg TE; Raivio M; Laakkonen ML; Pitkälä KH
    J Am Geriatr Soc; 2018 Dec; 66(12):2377-2381. PubMed ID: 30320427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychiatric Symptoms as Predictors of Clinical Course in Neurodegeneration. A Longitudinal Study.
    Santacruz Escudero JM; Beltrán J; Palacios Á; Chimbí CM; Matallana D; Reyes P; Perez-Sola V; Santamaría-García H
    Front Aging Neurosci; 2019; 11():176. PubMed ID: 31396074
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case-Control Study.
    Levada OA; Cherednichenko NV; Troyan AS
    Front Psychiatry; 2017; 8():75. PubMed ID: 28522977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
    Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
    Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of neuropsychological tests and the Neuropsychiatric Inventory in differential diagnosis between Frontotemporal dementia and Alzheimer's disease.
    Bahia VS; Viana R
    Dement Neuropsychol; 2009; 3(4):332-336. PubMed ID: 29213649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Appetite and Sarcopenia in Patients With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease: A Case-Control Study.
    Kimura A; Sugimoto T; Niida S; Toba K; Sakurai T
    Front Nutr; 2018; 5():128. PubMed ID: 30619874
    [No Abstract]   [Full Text] [Related]  

  • 37. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
    Vik-Mo AO; Giil LM; Ballard C; Aarsland D
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptoms in Alzheimer's disease: associations with caregiver burden and treatment outcomes.
    Chen CT; Chang CC; Chang WN; Tsai NW; Huang CC; Chang YT; Wang HC; Kung CT; Su YJ; Lin WC; Cheng BC; Su CM; Hsiao SY; Hsu CW; Lu CH
    QJM; 2017 Sep; 110(9):565-570. PubMed ID: 28383687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease.
    Lo TWB; Karameh WK; Barfett JJ; Fornazzari LR; Munoz DG; Schweizer TA; Fischer CE;
    Alzheimer Dis Assoc Disord; 2020; 34(2):141-147. PubMed ID: 31633557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease.
    Allegri RF; Sarasola D; Serrano CM; Taragano FE; Arizaga RL; Butman J; Loñ L
    Neuropsychiatr Dis Treat; 2006 Mar; 2(1):105-10. PubMed ID: 19412452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.